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Abstract
We measured the effects of epilepsy on visual contrast sensitivity to linear and vertical sine-wave gratings. Sixteen female 
adults, aged 21 to 50 years, comprised the sample in this study, including eight adults with generalized tonic-clonic seizure-type 
epilepsy and eight age-matched controls without epilepsy. Contrast threshold was measured using a temporal two-alternative 
forced-choice binocular psychophysical method at a distance of 150 cm from the stimuli, with a mean luminance of 40.1 cd/m2. 
A one-way analysis of variance (ANOVA) applied to the linear contrast threshold showed significant differences between groups 
(F[3,188] = 14.829; p < .05). Adults with epilepsy had higher contrast thresholds (1.45, 1.04, and 1.18 times for frequencies 
of 0.25, 2.0, and 8.0 cycles per degree of visual angle, respectively). The Tukey Honestly Significant Difference post hoc test 
showed significant differences (p < .05) for all of the tested spatial frequencies. The largest difference between groups was 
in the lowest spatial frequency. Therefore, epilepsy may cause more damage to the neural pathways that process low spatial 
frequencies. However, epilepsy probably alters both the magnocellular visual pathway, which processes low spatial frequencies, 
and the parvocellular visual pathway, which processes high spatial frequencies. The experimental group had lower visual contrast 
sensitivity to all tested spatial frequencies. Keywords: epilepsy, tonic-clonic seizures, contrast sensitivity,visual pathways.
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Introduction 
Epilepsy is a chronic neurological disorder, but no 
consensus has been reached about its accurate definition 
(Guerreiro & Guerreiro, 1996). It is characterized by 
recurrent and uncontrollable seizures that occur as a result 
of excessive electrical discharges in a group of brain 
cells. This sudden and usually brief alteration in brain 
activity is reversible, and different parts of the brain can 
elicit such discharges (Fonseca & Tedrus, 2004; Kaplan 
& Sandock, 1997; Lorenzato, Cavalli, & Duarte, 2002).
According to the World Health Organization 
(WHO, 2010), 50 million people in the world 
have epilepsy, with 40 million living in developing 
countries. Epilepsy can affect every age group, but it 
especially affects children younger than 2 years of age 
and the elderly above 65 years of age (Santo, Maineri, 
& Portuguez, 2004). 
Epilepsy can be classified into two main types: 
partial seizures and general seizures (Pinel, 2005). Partial 
seizures begin with an electrical discharge in one limited 
area of the brain, whereas general seizures begin with 
widespread electrical discharge that involves both sides 
of the brain at once. Epilepsy with general seizures can be 
divided into absence seizures, myoclonic seizures, tonic 
seizures, clonic seizures, and tonic-clonic seizures (Tedrus 
& Fonseca, 2005). Epilepsy with tonic-clonic seizures is 
the subtype with the highest prevalence (WHO, 2010). 
During tonic-clonic seizures, the patient initially presents 
a loss of conscience and falls, exhibiting rigidity shortly 
thereafter, and the extremities of the body begin to shake 
and contract (Guerreiro & Guerreiro, 1996).
Patients with epilepsy usually have visual 
problems that can be attributable to the pathology 
itself or to the drugs used to control seizures (Hilton, 
Cubbidge, Hosking, Betts, & Comaish, 2002; 
Mirabella et al., 2007; Verrotti, Manco, Matricardi, 
Franzoni, & Chiarelli, 2007). However, many studies 
have related epilepsy to visual perception, but these 
studies used different methodologies and samples 
that were poorly described only as patients with 
epilepsy or partial epilepsy (Hilton et al., 2002; Sorri, 
Rissanen, Mantyjarvi, & Kalviainen, 2005; Sorri, 
Kalviainen, & Mantyjarvi, 2005).
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For example, Mirabela et al. (2007) developed a study 
that investigated visual deficits in children, with seizure-
type epileptic infants either taking no medicine, receiving 
vigabatrin (VGB), or taking other antiepileptic drugs. They 
measured contrast sensitivity (CS) using the sweep visual 
evoked potential method. They found that the decreased 
CS was not related to VGB but rather to epileptic seizures 
because the deficit began before the administration of the 
drug and did not become worse with VGB.
In two studies, Sorri et al. tested CS in patients with 
partial epilepsy treated with tiagabine monotherapy 
(Sorri et al., 2005a) and valproate monotherapy (Sorri et 
al., 2005b). Both studies found no changes in CS.
Tomson, Nilsson, and Levi (1988) measured CS in 
epileptic patients treated with carbamazepine to verify 
whether this drug could reduce psychophysical CS. They 
found a reduction in CS in the epileptic group treated with 
carbamazepine compared with the control group (i.e., 
without epilepsy). No conclusion could be made from these 
results, however, that the decrease in CS was attributable 
to carbamazepine or epilepsy. This difficulty separating the 
effects of medications from the effects of epilepsy is very 
common in the literature (Verrotti et al., 2007). 
The aim of the present study was to examine the 
effects of tonic-clonic seizure-type epilepsy on visual CS 
using the psychophysical staircase method with forced 
choice between two temporal alternatives. Previous 
studies investigated other epilepsy types and used 
psychophysical methods that did not minimize the effects 
of the criteria of the participants’ response choice (García-
Pérez, 1998; Schwartz, 2004). Therefore, this may be one 
reason why the psychophysical forced-choice method is 
one of the most widely used methods in the literature.
Methods
Participants
Sixteen female volunteers, aged 21 to 50 years 
(mean = 26.6; SD = 7.5), comprised the sample, 
including eight adults with congenital generalized 
tonic-clonic seizure-type epilepsy (experimental 
group [EG]) and eight age-matched controls without 
epilepsy (control group [CG]). The volunteers from 
the EG were taking carbamazepine, phenobarbital, and 
oxicarbazepine (for more information, see Yacubian 
[1999] and Garzon [2002]) for at least 4 years. All of 
the volunteers had normal visual acuity (6/6, inclusion 
criterion) tested with directional “E” Rasquin optotype 
cards (Xenonio, São Paulo, SP, Brazil) and were free of 
eye or neurological diseases (exclusion criterion), with 
the exception of epilepsy in the EG. The participation of 
all volunteers adhered to ethical considerations relevant 
to research that involves human subjects according 
to resolution 196/96 of the National Health Council, 
Health Ministry, Brazil. The experimental design 
was approved by the Ethics Committee of the Health 
Sciences Centre, Universidade Federal da Paraíba. The 
subjects’ participation was voluntary and commenced 
after they signed an informed consent.
Adults with tonic-clonic epileptic seizures were 
diagnosed by neurologists and electroencephalographic 
tests. These patients were selected at the Hospital 
Universitário Lauro Wanderley, a public hospital at the 
Universidade Federal da Paraíba, Brazil.
Visual stimuli
The achromatic and circular stimuli had a diameter 
of approximately 7.2º of the visual angle and were 
generated in grayscale, with an average luminance of 
40.1 cd/m2. The neutral stimulus was gray and contained 
only the average luminance. The test stimuli were linear, 
vertical, and static sine-wave gratings (Campbell & 
Green, 1965) and were defined in Cartesian coordinates 
(0.25, 2.0, and 8.0 cycles per degree of visual angle 
[cpd]) as the following:
L(x) is the luminance at a point on the sine-wave. Lm 
is the average luminance. c is the contrast. f is frequency 
in cpd. F is the spatial phase. In this case, contrast is 
defined by the following formula (Michelson, 1891):
C is the contrast. Lmax is the maximum luminance. 
Lmin is the minimum luminance.
Equipment
The stimuli were set to appear in the center of the 
video monitor, 150 cm from the observer (Figure 1). 
A fixed chair and forehead-chin support were used to 
control the distance. The monitor used to generate and 
present the stimuli was a color cathode ray tube (CRT) 
with a 19-inch screen, 1024 x 768 resolution, and 70 Hz 
image update frequency controlled by a microcomputer 
through VGA and DVI video connectors.
The dynamic range proportion of the monitor was 
expanded more than 64 times by a BITS++ digital video 
processor (Cambridge Research Systems, Rochester, 
UK). The 8 bits per channel or 24 bits per pixel that 
exist in common monitors, equivalent to 256 levels in 
grayscale, were expanded to 14 bits per channel or 42 
bits per pixel, equivalent to more than 16,384 levels 
in grayscale, enabling the use of a computer to run the 
experiments with high-contrast resolution. BITS++ 
worked with software developed by our group, written 
in C++ language, to generate the stimuli, control the 
presentation, and record the contrast threshold values.
The LightScan program with an Optical photometer 
(Cambridge Research Systems) measured screen 
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luminance and performed gamma correction using all 
256 points from 0-255 as the sample (gamma = 1.8), 
which is indicated when using BITS++. The minimum 
and maximum luminance values of the screen were 
0.20 cd/m2
 
and 80.0 cd/m2, respectively (average 
luminance, 40.1 cd/m2). The background luminance 
was the minimum luminance itself. The laboratory room 
measured 2.5 x 2.0 m and was illuminated by one Philips 
20 W fluorescent lamp. The walls were gray to enable 
better control of ambient lighting during the experiment.
Procedure
The visual CS of all participants was estimated 
using the psychophysical staircase method, with a 
forced choice between two temporal alternatives as 
originally proposed by Wetherill and Levitt (1965). 
The forced-choice method is based on the probability 
of consecutive hits by the volunteer (i.e., approximately 
100 opportunities to choose between two stimuli). In 
this case, with each pair of stimuli, one only had the 
mean luminance (40.1 cd/m2; i.e., neutral stimulus), and 
the other contained one of the spatial frequencies (i.e., 
test stimulus). The test stimuli (sinusoidal vertical linear 
sine-wave gratings) are seen approximately 79% of the 
time by the volunteer.
The procedure for measuring the threshold for each 
frequency consisted of presenting successive pairs of 
simple stimuli, in which one was the test stimulus that 
should be identified by the participant (the first or second 
stimulus of each pair). The order of the presentation of 
the stimuli and frequencies was random and controlled 
by the software. The criterion used to measure the CS 
for each spatial frequency was three consecutive hits to 
decrease 20% of the remaining contrast and an error of 
increasing contrast by the same percentage.
In this type of procedure, the number of 
presentations of the stimulus pairs is variable and 
depends on the success of the volunteer and the number 
of previously defined threshold values. In the present 
study, each experimental session ended automatically 
after six threshold values (three maximum and three 
minimum values due to the staircase method) or six 
Figure 1. Stimulus presentation scheme. The stimuli were 
originally calibrated to be seen at a distance of 150 cm on a 
19-inch display.
reversals obtained by the volunteer, which took an 
average of 5 to 10 min.
A stimulus sequence was presented during each 
experimental session, beginning with a beep followed 
immediately by the presentation of the first stimulus for 
2 s. A 1 s interval occurred between stimuli, followed 
by the presentation of the second stimulus for 2 s and 
the volunteer’s response. A correct response by the 
volunteer was followed by another beep. The interval 
between trials was 3 s, regardless of whether the answer 
(or choice) was correct or wrong. The beeps that 
indicated the beginning of the stimulus pair presentation 
and the correct choice were different.
All participants received the following statement: 
“Pairs of circles will appear on the screen, one after 
the other. One of them will be totally gray, whereas 
the other will contain light and dark stripes. When the 
circle with stripes appears first, you must press the left 
mouse button (button 1); when the circle with stripes 
appears in the second place, you should press the right 
mouse button (button 2).”
Notably, each session began with the test stimulus 
with contrast at the supra-threshold level, and the 
experiments only began when the experimenter 
was sure that the participants understood and 
responded according to the directions. In this 
context, instructions were repeated in a training 
and familiarization session under the experimental 
conditions. All measurements were performed with 
binocular vision and normal pupils.
After each experimental session, the software 
produced a record sheet with the threshold contrast 
values, six in the test and six in the retest. Values 
were grouped according to the experimental 
condition (i.e., adults with epilepsy [EG] and adults 
without epilepsy [CG]).
Results
To perform a parametric analysis, we confirmed 
that the threshold values for both groups had a 
normal distribution using Kolmogorov-Smirnov’s 
test and homogeneity of variance using Levine’s 
test. The outlier values were considered missing 
case using Tukey’s outlier test. The median contrast 
threshold values for each participant was then used 
for the data analyses.
One-way analysis of variance (ANOVA) applied 
to visual CS showed significant differences between 
groups (F[3,188] = 14.829; p < .05). Adults with 
epilepsy had higher contrast thresholds that reached 
approximately 1.45, 1.04, and 1.18 times for the 
frequencies of 0.25, 2.0, and 8.0 cpd, respectively 
(Figure 2). The Tukey Honestly Significant Difference 
post hoc test showed significant differences (p < .05) 
for all of the tested spatial frequencies.
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Discussion
The present study measured luminance CS in 
participants without any neuropsychiatric disease and 
patients with epilepsy using the psychophysical staircase 
method with forced choice between two options at a 
photopic luminance level. The aim of this research 
was to verify whether epilepsy alters the response of 
the visual system or basic sensory mechanisms related 
to the processing of luminance contrast in sine-wave 
gratings of 0.25, 2.0, and 8.0 cpd.
The present study was based on the hypothesis that 
most diseases that change or affect the nervous system, 
including epilepsy, cause structural, functional, and 
behavioral changes in humans (Hilton et al., 2002). 
Consistent with this hypothesis, visual neuroscience 
research uses visual CS to evaluate and diagnose changes 
in optic and neural structures related to diseases that are 
not directly related to visual changes, such as depression 
(Wesner & Tan, 2006), schizophrenia (Slaghuis & 
Thompson, 2003), and malnutrition (Santos, Alencar, 
& Dias, 2009; Santos & Alencar, 2010), among others.
The results showed that visual CS in the CG and 
EG had similar patterns, with maximum sensitivity to 
the medium spatial frequency (2.0 cpd) and a decrease 
in visual CS in response to the lowest spatial frequency 
(0.25) and highest spatial frequency (8.0 cpd). However, 
the statistical analyses revealed significant differences 
between groups at all of the tested spatial frequencies 
(0.25, 2.0, and 8.0 cpd). The largest difference between 
groups was with the lowest spatial frequency. Patients 
with epilepsy needed 1.5 more contrast to detect it. 
Therefore, epilepsy may cause more damage to the 
neural pathways that preferentially process low spatial 
frequencies. According to Souza, Gomes, Saito, da Silva 
Filho, and Silveira (2007), at low spatial frequencies 
(i.e., 0.4-0.8 cpd), only the magnocellular visual pathway 
appears to be relevant for the cortical response. However, 
because the EG had lower visual CS in response to all 
tested spatial frequencies, epilepsy may alter both the 
magnocellular visual pathway, which preferentially 
processes low spatial frequencies, and parvocellular 
visual pathway, which preferentially processes high 
spatial frequencies (Burbeck & Kelly, 1981). Lee (2011) 
stated that the way in which central pathways process 
afferent inputs in more complex spatial contexts makes 
such correlations less clear, but the identification of 
psychophysical luminance channels with afferent visual 
pathways may remain valid for simple detection tasks. 
The effects of epilepsy on these visual pathways needs 
to be investigated further with specific stimuli designed 
to independently stimulate them, although this was not 
the aim of the present research.
Decreases in visual CS in the EG was expected 
because this study measured visual CS in adults with 
generalized tonic-clonic seizure-type epilepsy, one 
of the most severe forms of epilepsy that changes 
several different areas of the nervous system (Kaplan 
& Sandock, 1997; Lorenzato et al., 2002; Fonseca & 
Tedrus, 2004). These data are consistent with previous 
reports that found epilepsy-related damage to the visual 
system and decreased CS (Nousiainen, Kalviainen, & 
Mantyjarvi, 2000; Mirabela et al., 2007).  
Our laboratory is developing new research to evaluate 
whether this damage is caused by the epilepsy itself or 
anticonvulsant treatment, for which no consensus has yet 
been reached (Tomson et al., 1988; Verrotti, Ciampani, 
Pomilio, Latini, & Chiarelli, 2006). Mirabella et al. 
(2007) found reduced visual CS in children with infantile 
seizures who were not using any drugs. However, several 
other studies showed that anticonvulsant drugs, such as 
carbamazepine, alter visual function (Tomson et al., 1988; 
Sartucci et al., 1997; Steinhoff, Freudenthaler, & Paulus, 
1997). Nousiainen et al. (2000) did not find changes in 
visual function related to carbamazepine treatment in 
volunteers with epilepsy. The effects of anticonvulsants on 
visual perception and the nervous system need to be better 
analyzed to solve the contradictions found in the literature.
In the present study, the volunteers in the EG were all 
taking drugs, including carbamazepine, oxicarbazepine, 
and phenobarbital, for more than 4 years. Finding 
volunteers with generalized tonic-clonic seizure-type 
epilepsy who are not taking any medications is difficult. 
We found a significant decrease in visual CS related to 
epilepsy, but we cannot conclude that this was caused 
only by epilepsy or whether it was attributable to both 
epilepsy and anticonvulsant drugs. 
In summary, evaluating the effects of epilepsy on 
visual CS using the psychophysical method is a valuable 
in vivo, noninvasive tool for assessing the effects of 
epilepsy and the drugs used to treat epilepsy patients on 
Figure 2. The estimated visual contrast threshold in female adult 
volunteers is shown as a spatial frequency function of 0.25, 2.0, 
and 8.0 cpd. The mean error bars were corrected to the sample’s 
size to represent a 95% confidence interval. The continuous 
curve (─■─) represents the contrast threshold of adults with 
generalized tonic-clonic seizure-type epilepsy (experimental 
group), and the dotted curve (---●---) represents the contrast 
threshold of adults without epilepsy (control group).
Visual contrast sensitivity and epilepsy 79
the central nervous system in humans. Such a method 
may also be useful for disease diagnosis, prognosis, and 
treatment follow-up.
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